Short Interest in Bavarian Nordic A/S (OTCMKTS:BVNRY) Decreases By 66.7%

Bavarian Nordic A/S (OTCMKTS:BVNRY) was the target of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 400 shares, a decrease of 66.7% from the October 31st total of 1,200 shares. Based on an average daily volume of 81,400 shares, the days-to-cover ratio is presently 0.0 days.

Bavarian Nordic A/S Price Performance

Shares of OTCMKTS:BVNRY traded up $0.11 during trading on Friday, reaching $9.10. The stock had a trading volume of 27,793 shares, compared to its average volume of 33,347. The stock has a market capitalization of $2.15 billion, a PE ratio of 13.03 and a beta of 1.71. Bavarian Nordic A/S has a 52 week low of $6.86 and a 52 week high of $14.60. The business’s 50-day moving average price is $10.26 and its 200 day moving average price is $9.93.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.